DCB in de novo lesions: new valid option?

Facilitators: A. Colombo, T. Schmitz

Speakers: A. Sakalidis, N. Y. Sulaiman, A. R. Pereira, I. Iveljic, H. O. Arabaci

Summary

Explore the emerging role of drug-coated balloons (DCB) in treating de novo coronary lesions. This session discusses complexity management, comparisons with drug-eluting stents (DES), and the potential of DCBs as valuable alternatives, especially in high bleeding risk patients.

Presentations available when logged in:

Traceless touch
Tackling Complexity: DCB use in left main and diffuse left anterior descending artery disease
DEB: ready for the prime time?
It is all about decisions: DES or DCB
DEB vs. DES: a valuable alternative for high bleeding risk patient

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

DCB in de novo lesions: new valid option?

Log in or create account for free